US court dismisses lawsuit against Emcure over Covid-19 vaccine, ET LegalWorld | Court Practice News


A US Court has dismissed a lawsuit filed by HDT Bio Corp against Pune-based Emcure Pharmaceuticals. A Federal court in Seattle, Washington, has dismissed the lawsuit lawsuit filed by HDT against Emcure regarding Covid-19 vaccine technology.

HDT had named Emcure as a party in the suit, alleging non-payment of royalties and demanded a compensation of at least USD 950 million.

When contacted a company spokesperson said, “The ruling vindicates our stand”.

Emcure had contended in the court that the lawsuit was illegitimate and brought by HDT to compensate for its business shortcomings.

HDT Bio had alleged that the Pune-based firm had stolen its vaccine technology which it had licensed to Gennova for manufacture and distribution in India.

  • Published On Dec 6, 2023 at 12:01 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETLegalWorld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App



Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Prince Harry in UK court battle over security, Legal News, ET LegalWorld | Court Practice News

Tue Dec 5 , 2023
Lawyers for Prince Harry on Tuesday began a legal challenge over his security arrangements in the UK, after he quit frontline royal duties and moved to North America. The case about his loss of UK taxpayer-funded protection is the latest in a string of court proceedings initiated by Harry, whose […]

You May Like

Breaking News